FLEX's Subsidiary Nextracker Files for an IPO Offering

02:14pm, Monday, 16'th Jan 2023 Zacks Investment Research
Flex's subsidiary, Nextracker, plans to launch an IPO to offer Class A common stock.

Here's Why Investors Should Consider Buying Pure Storage (PSTG)

01:09pm, Friday, 13'th Jan 2023 Zacks Investment Research
Pure Storage's (PSTG) performance is benefiting from the growing demand for its FlashArray and FlashBlade businesses.

Calix (CALX) Is Up 5.75% in One Week: What You Should Know

05:00pm, Tuesday, 06'th Dec 2022 Zacks Investment Research
Does Calix (CALX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Does Calix (CALX) have what it takes to be a top stock pick for momentum investors? Let's find out.
Brian Smoluch, Hood River Capital Management principal, joins 'The Exchange' to offer his case for small caps over large caps.
Calix is the IBD Stock Of The Day as shares of the telecom network gear maker rebound off their 21-day exponential moving average in solid volume. The post Telecom Gear Maker Calix Rides Fiber-To-Hom

Best Momentum Stocks to Buy for October 31st

02:00pm, Monday, 31'st Oct 2022 Zacks Investment Research
HAL, CALX and FLEX made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on October 31, 2022.
Owing to federal broadband funding for rural areas and next-gen cloud computing, telecom infrastructure stands out as an area of high investment. The post Digital Divide: Can Federal Funding For Rural
Credit Suisse raised Visa Inc. (NYSE: V) price target from $235 to $245. Credit Suisse analyst Moshe Orenbuch maintained the stock with an Outperform rating. Visa shares rose 1.9% to close at $194.38
Gainers Taysha Gene Therapies, Inc. (NASDAQ: TSHA) surged 97.4% to close at $2.98 after Astellas Pharma Inc announced it will invest a total of $50 million to acquire 15% of the company. Fangdd Netwo
Needham analyst Ryan Koontz reiterated a Buy rating on Calix, Inc (NYSE: CALX) with a $70 price target. CALX reported a strong beat and raise, with 3Q22 revenue and non-GAAP EPS beating the consen
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 83% to $0.4499 after the company announced results in a preclinical model of acute and chronic kidney disease. Treatment with REVTx-300 sign
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Tuesday. Here are some big stocks recording gains in today’s session. Medpace Holdings, Inc. (NASDAQ: MEDP) shares jum
Calix, Inc. (NYSE:CALX ) Q3 2022 Earnings Conference Call October 25, 2022 8:30 AM ET Company Participants Jim Fanucchi - Investor Relations Carl Russo - Chairman Michael Weening - President and Chief

Calix (CALX) Beats Q3 Earnings and Revenue Estimates

09:45pm, Monday, 24'th Oct 2022 Zacks Investment Research
Calix (CALX) delivered earnings and revenue surprises of 41.67% and 10.01%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE